SCHEMBL19862234

SCHEMBL19862234

Cc1cccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)C3(c5ccccc5C=C4)c4ccccc4-c4c3ccc3oc5ccccc5c43)n2)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1I3 Q14994 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.32
RAB9A P51151 3/20 0.32
MAPT P10636 2/20 0.32
NPC1 O15118 2/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
KDM4E B2RXH2 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C19 P33261 1/20 0.32
PDK2 Q15119 1/20 0.31
ENPP3 O14638 1/20 0.31
ABCB1 P08183 1/20 0.31
ABCG2 Q9UNQ0 1/20 0.31
MEN1 O00255 3/20 0.31
KMT2A Q03164 3/20 0.31
GAA P10253 1/20 0.31
TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19862126 0.94 WEE1 (0.31) ALDH1A1HPGDKMT2A
SCHEMBL19862241 0.93 WEE1 (0.30)
SCHEMBL19862245 0.92 PLA2G2A (0.31) PIM1CSNK2A2CSNK2B
SCHEMBL19862238 0.89 KMT2A (0.33) MAPTALDH1A1HPGDKDM4EMEN1
SCHEMBL20224476 0.89 PDK2 (0.38) NR1I3SMN1; SMN2RAB9AMAPTNPC1
SCHEMBL19862249 0.89 KMT2A (0.32) MAPTALDH1A1HPGDKDM4EMEN1
SCHEMBL19862240 0.86 PDK2 (0.35) SMN1; SMN2RAB9AMAPTNPC1ALDH1A1
SCHEMBL19862173 0.86 NR1I3 (0.35) NR1I3SMN1; SMN2RAB9AMAPTNPC1
SCHEMBL19862244 0.85
SCHEMBL19862254 0.85 MEN1 (0.30) MAPTALDH1A1HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180047918-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180047918-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME ORC3, AOX1, RCOR3 NR1I3 496/4885SMN1; SMN2 3862/4885RAB9A 450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.